2016 Digestive Disease Week

Caroline Helwick / June 25, 2016 / 2016 Digestive Disease Week

Expert Point of View: Samir Gupta, MD

Samir Gupta, MD, Associate Professor of Medicine at the University of California San Diego, who has led trials of colorectal cancer screening, commented on this study for The ASCO Post. Although the...

Colorectal Cancer

Caroline Helwick / June 25, 2016 / 2016 Digestive Disease Week

Young-Onset Colorectal Cancer Diagnoses Rising

Colorectal cancer is being increasingly diagnosed in persons younger than age 50, the age at which colorectal cancer screening is usually initiated. According to Elie Sutton, MD, of Mount Sinai West...

Aug

Today In Oncology

Early-Phase Study Finds Vitamin C May Activate TET2 Function

Comparison of Screening Recommendations for Mammography

Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism

Adjuvant Temozolomide in 1p/19q Non-Codeleted Anaplastic Glioma

2016 Digestive Disease Week

Expert Point of View: Samir Gupta, MD

Young-Onset Colorectal Cancer Diagnoses Rising

Early-Phase Study Finds Vitamin C May Activate TET2 Function

Comparison of Screening Recommendations for Mammography

Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism

Adjuvant Temozolomide in 1p/19q Non-Codeleted Anaplastic Glioma

AKT Inhibitor Ipatasertib in Metastatic Triple-Negative Breast Cancer

Liquid Biopsies Identify Distinct Genomic Profiles With Potentially Targetable Alterations in Carcinoma of Unknown Primary

Detection of Early-Stage Cancers With Circulating Tumor DNA

Arsenic Trioxide and Reduced Anthracycline Dose in Pediatric Acute Promyelocytic Leukemia

FDA Approves Olaparib Tablets for Maintenance Treatment in Ovarian Cancer

First-Line Cabazitaxel vs Docetaxel in Metastatic Castration-Resistant Prostate Cancer

Partial-Breast and Reduced-Dose Radiotherapy After Breast-Conserving Surgery

Searching for Happiness

ASCO Guideline on Stage IV NSCLC Therapy Updated

KEYNOTE-010 Update Shows ‘Striking’ Durability of Second-Line Pembrolizumab in NSCLC

Surveillance Mammography by Life Expectancy in Older Breast Cancer Survivors

Final Overall Survival Results of GOG 240 Trial Adding Bevacizumab to Chemotherapy in Advanced Cervical Cancer

Genomic Characteristics and Immune Infiltration in Triple-Negative Breast Cancer

CheckMate-214: Nivolumab and Ipilimumab in Intermediate- and Poor-Risk Previously Untreated Advanced or Metastatic RCC